Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Molecular Cancer Therapeutics|November 21, 2007
Blocking heat shock protein-90 inhibits the invasive properties and hepatic growth of human colon cancer cells and improves the efficacy of oxaliplatin in p53-deficient colon cancer tumors in vivoChristian Moser, Sven A Lang, Silvia Kainz, et al.
Therapeutic Advances in Medical Oncology|October 3, 2022
A new promising oncogenic target (p.C382R) for treatment with pemigatinib in patients with cholangiocarcinomaLouisa Hempel, Constantin Lapa, Alexander Dierks, et al.
Molecular Cancer Therapeutics|March 17, 2007
Inhibition of heat shock protein 90 impairs epidermal growth factor-mediated signaling in gastric cancer cells and reduces tumor growth and vascularization in vivoSven A Lang, Dagmar Klein, Christian Moser, et al.
Frontiers in Cell and Developmental Biology|January 11, 2021
Extracellular Citrate Fuels Cancer Cell Metabolism and GrowthSebastian Haferkamp, Konstantin Drexler, Marianne Federlin, et al.
Acta Histochemica|October 23, 2002
New aspects in the histological examination of polyethylene wear particles in failed total joint replacementsTorsten Hansen, Mike Otto, Gottfried H Buchhorn, et al.
Scientific Reports|June 28, 2020
Real world data analysis of next generation sequencing and protein expression in metastatic breast cancer patientsDirk Hempel, Florian Ebner, Arun Garg, et al.
Rheumatology International|March 14, 2003
Expression of the apoptosis accelerator Bax in rheumatoid arthritis synoviumInsa Hilbers, Torsten Hansen, Peter K Petrow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2007
Targeting heat shock protein 90 in pancreatic cancer impairs insulin-like growth factor-I receptor signaling, disrupts an interleukin-6/signal-transducer and activator of transcription 3/hypoxia-inducible factor-1alpha autocrine loop, and reduces orthotopic tumor growthSven A Lang, Christian Moser, Andreas Gaumann, et al.
American Journal of Respiratory Cell and Molecular Biology|March 8, 2008
Spatiotemporal expression of flk-1 in pulmonary epithelial cells during lung developmentKatrin Ahlbrecht, Judith Schmitz, Ulrike Seay, et al.
International Journal of Cancer|January 19, 2007
Mammalian target of rapamycin is activated in human gastric cancer and serves as a target for therapy in an experimental modelSven A Lang, Andreas Gaumann, Gudrun E Koehl, et al.
Pageof 6